Assignee
SHANGHAI MAIUS PHARMACEUTICAL CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0154US2026055111A1Crystalline form of pyrazolopyrimidine ester compound and methods of preparing the sameSHANGHAI MAIUS PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0247US2025092010A1Dihydro-2h-isoindole ester compoundSHANGHAI MAIUS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0347US2024360144A1Pyrazolopyrimidine ester compoundSHANGHAI MAIUS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0444US2026055112A1Crystalline form of pyrazolopyrimidine ester compound and methods of preparing the sameSHANGHAI MAIUS PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI MAIUS PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →